HomeNewsBusinessMarketsDAILY VOICE | ‘Out-of-home’ and discretionary segments to come under pressure in coming 1-2 quarters: Amnish Aggarwal of Prabhudas Lilladher

DAILY VOICE | ‘Out-of-home’ and discretionary segments to come under pressure in coming 1-2 quarters: Amnish Aggarwal of Prabhudas Lilladher

The current bout of uncertainty makes it difficult to judge the actual impact of COVID-19 on consumer demand and corporate profits in the medium term, says Aggarwal.

May 10, 2021 / 08:52 IST
Story continues below Advertisement

Amnish Aggarwal, Head – Research, Institutional Equities, Prabhudas Lilladher, said that ‘out-of-home’ and discretionary segments could come under pressure in the coming 1-2 quarters as top 10 cities account for nearly 40% of India’s consumption and they seem to be facing the brunt of Covid-19.

Aggarwal has about 17 years of experience in Indian financial markets. A Post graduate in Finance from ICFAI, he started his career as a Research Analyst with First Global Securities. Although he looks at the entire gamut of sectors, his expertise lies in consumption-related sectors.

Story continues below Advertisement

In an interview with Moneycontrol's Kshitij Anand, Aggarwal said that he is cautiously optimistic on the markets in the long term, but for now it seems to be ignoring a possible downgrade in earnings led by localised lockdowns and the impact on consumer sentiment due to the second wave of Covid-19.

Edited excerpts:-

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show